Clinical Trials Directory

Trials / Completed

CompletedNCT03816410

Natriuretic Peptides After Left Atrial Appendage Amputation

Influence of Left Atrial Appendage Amputation on Natriuretic Peptides - a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of Giessen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Surgical amputation of the left atrial appendage (LAA) is an established intervention during surgical atrial fibrillation (AF) therapy. However, its effects on the endocrine function of the left atrium are unclear. This study aims to quantify the serum levels of natriuretic peptides in patients who undergo concomitant surgical AF ablation with or without LAA amputation.

Conditions

Interventions

TypeNameDescription
PROCEDURELAA amputationcomplete surgical amputation of the left atrial appendage

Timeline

Start date
2015-05-01
Primary completion
2015-10-30
Completion
2018-12-01
First posted
2019-01-25
Last updated
2019-01-25

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03816410. Inclusion in this directory is not an endorsement.

Natriuretic Peptides After Left Atrial Appendage Amputation (NCT03816410) · Clinical Trials Directory